Details
| Stereochemistry | MIXED |
| Molecular Formula | C20H24N2O5 |
| Molecular Weight | 372.415 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CCC1=CC2=C(OCO2)C=C1)NCC(O)C3=CC(C(N)=O)=C(O)C=C3
InChI
InChIKey=MPQWSYJGFLADEW-UHFFFAOYSA-N
InChI=1S/C20H24N2O5/c1-12(2-3-13-4-7-18-19(8-13)27-11-26-18)22-10-17(24)14-5-6-16(23)15(9-14)20(21)25/h4-9,12,17,22-24H,2-3,10-11H2,1H3,(H2,21,25)
| Molecular Formula | C20H24N2O5 |
| Molecular Weight | 372.415 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Medroxalol is a competitive antagonist at alpha1-adrenergic receptors and beta1-adrenergic receptors. Medroxalol also an agonist at beta2-adrenergic receptors. Medroxalol exerts antihypertensive and vasodilating effects. It was concluded that the principal action of medroxalol was to produce a fall in blood pressure by decreasing peripheral vascular resistance more than cardiac output.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Antihypertensive and vasodilating effects of acute medroxalol, a new beta-blocker with beta-2-adrenergic receptor stimulation. | 1986-07-01 |
|
| Analysis of the hypotensive effects of medroxalol and its enantiomers, MDL 17,330A and MDL 17,331A. | 1984 |
|
| Cardiovascular properties of medroxalol, a new antihypertensive drug. | 1981-03-01 |
|
| Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol. | 1980-12-22 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:52:11 GMT 2025
by
admin
on
Mon Mar 31 17:52:11 GMT 2025
|
| Record UNII |
7PX96289JA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
56290-94-9
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
4784
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
C024892
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
41835
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
DTXSID30866550
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
C167041
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
CHEMBL113278
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
7PX96289JA
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
SUB08698MIG
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
260-099-3
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
100000081992
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
1658
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY | |||
|
Medroxalol
Created by
admin on Mon Mar 31 17:52:11 GMT 2025 , Edited by admin on Mon Mar 31 17:52:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |